IRADIMED CORPORATION IRMD
Set alert
79.42 USD +2.74 +3.57%
At close
79.55 +0.13 +0.16%
Pre-market · Nov 3, 6:16 AM ET
77.56 Day range 80.02
76.35 52-week range 107.90
- YTD
- -18.36%
- 1 year
- -5.58%
- Open
- 77.57
- Prev close
- 76.68
- Mkt cap
- 1.02B
- Vol
- 203.50K
- Avg vol
- 122.29K
- EPS
- 1.87
- P/E
- 42.47
- Div yield
- 0.93%
More statistics
- Low
- 77.56
- High
- 80.02
- Forward P/E
- 32.64
- Beta
- 0.94
- Short ratio
- 5.23
- Inst. own
- 62.70%
- Dividend
- 0.80
- Ex-div date
- Aug 13, 2026
- Earnings
- Feb 9, 2027
- 50-d avg
- 85.66
- 200-d avg
- 92.54
- 1y target
- 118.00
6M chart
Events in this range
- May 15, 2026Dividend: 0.2
- Jul 31, 2026Earnings: 0.46; estimate 0.44; surprise 4.55%
- Aug 14, 2026Dividend: 0.2
- Sep 22, 2026Rating: Needham · — → Hold
- Oct 30, 2026Earnings: 0.55; estimate 0.55; surprise 0%
Signals (34)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| RSI: Oversold | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
Newest 20 of 34.
Analyst view
Consensus: buy
Buy
Price target (mean) 118.00 +48.6% upside
Now 79.42
- Target (low)
- 116.00
- Target (mean)
- 118.00
- Target (high)
- 120.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.63 | 0.61 – 0.66 | 0.54 | +16.7% | 26.23M | +15.6% | 3 |
| Next quarter | 0.58 | 0.57 – 0.59 | 0.49 | +18.4% | 25.00M | +13.7% | 2 |
| Current year | 2.11 | 2.09 – 2.16 | 1.93 | +9.5% | 92.07M | +9.9% | 3 |
| Next year | 2.45 | 2.40 – 2.54 | 2.11 | +16.1% | 104.10M | +13.1% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2026 | Needham | Initiated | — | Hold |
| Apr 2, 2026 | Freedom Broker | Initiated | — | Buy |
| Feb 14, 2025 | Roth MKM | Reiterated | Buy | Buy |
| Aug 2, 2024 | Roth MKM | Maintained | Buy | Buy |
| Aug 2, 2021 | Roth Capital | Maintained | — | Buy |
| Jul 31, 2017 | Roth Capital | Upgrade | Neutral | Buy |
| Oct 5, 2016 | Roth Capital | Downgrade | Buy | Neutral |
| Apr 4, 2016 | Roth Capital | Maintained | — | Buy |
| Jun 16, 2015 | Roth Capital | Maintained | — | Buy |
| Aug 11, 2014 | Roth Capital | Initiated | — | — |